|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 5143 |
FusionGeneSummary for CAB39L_USP12 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: CAB39L_USP12 | Fusion gene ID: 5143 | Hgene | Tgene | Gene symbol | CAB39L | USP12 | Gene ID | 81617 | 219333 |
| Gene name | calcium binding protein 39 like | ubiquitin specific peptidase 12 | |
| Synonyms | MO25-BETA|MO2L|bA103J18.3 | UBH1|USP12L1 | |
| Cytomap | 13q14.2 | 13q12.13 | |
| Type of gene | protein-coding | protein-coding | |
| Description | calcium-binding protein 39-likeMO25betaU937-associated antigenantigen MLAA-34mo25-like proteinsarcoma antigen NY-SAR-79 | ubiquitin carboxyl-terminal hydrolase 12deubiquitinating enzyme 12ubiquitin specific protease 12 like 1ubiquitin thioesterase 12ubiquitin thiolesterase 12ubiquitin-hydrolyzing enzyme 1ubiquitin-specific-processing protease 12 | |
| Modification date | 20180523 | 20180519 | |
| UniProtAcc | Q9H9S4 | O75317 | |
| Ensembl transtripts involved in fusion gene | ENST00000355854, ENST00000347776, ENST00000409308, ENST00000410043, ENST00000409130, ENST00000476943, | ENST00000282344, | |
| Fusion gene scores | * DoF score | 5 X 5 X 4=100 | 3 X 3 X 3=27 |
| # samples | 5 | 3 | |
| ** MAII score | log2(5/100*10)=-1 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(3/27*10)=0.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context | PubMed: CAB39L [Title/Abstract] AND USP12 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | USP12 | GO:0016579 | protein deubiquitination | 19075014|24145035 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | RV | PRAD | TCGA-HC-7230-01A | CAB39L | chr13 | 49906083 | - | USP12 | chr13 | 27649525 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| Frame-shift | ENST00000355854 | ENST00000282344 | CAB39L | chr13 | 49906083 | - | USP12 | chr13 | 27649525 | - |
| Frame-shift | ENST00000347776 | ENST00000282344 | CAB39L | chr13 | 49906083 | - | USP12 | chr13 | 27649525 | - |
| Frame-shift | ENST00000409308 | ENST00000282344 | CAB39L | chr13 | 49906083 | - | USP12 | chr13 | 27649525 | - |
| Frame-shift | ENST00000410043 | ENST00000282344 | CAB39L | chr13 | 49906083 | - | USP12 | chr13 | 27649525 | - |
| Frame-shift | ENST00000409130 | ENST00000282344 | CAB39L | chr13 | 49906083 | - | USP12 | chr13 | 27649525 | - |
| intron-3CDS | ENST00000476943 | ENST00000282344 | CAB39L | chr13 | 49906083 | - | USP12 | chr13 | 27649525 | - |
Top |
FusionProtFeatures for CAB39L_USP12 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| CAB39L | USP12 |
| Component of a complex that binds and activatesSTK11/LKB1. In the complex, required to stabilize the interactionbetween CAB39/MO25 (CAB39/MO25alpha or CAB39L/MO25beta) andSTK11/LKB1 (By similarity). {ECO:0000250}. | Deubiquitinating enzyme. Has almost no deubiquitinatingactivity by itself and requires the interaction with WDR20 andWDR48 to have a high activity (PubMed:19075014, PubMed:27373336).Not involved in deubiquitination of monoubiquitinated FANCD2(PubMed:19075014). In complex with WDR48, acts as a potentialtumor suppressor by positively regulating PHLPP1 stability(PubMed:24145035). {ECO:0000269|PubMed:19075014,ECO:0000269|PubMed:24145035, ECO:0000269|PubMed:27373336}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for CAB39L_USP12 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for CAB39L_USP12 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| CAB39L | BCKDK, STK11, MLH1, MX1, STRADA, CAB39, ACOT7, DCXR | USP12 | DHX8, DMWD, MMP2, PAIP1, RAD51AP1, USP39, PHLPP2, PHLPP1, NUP160, SDF4, UCHL5, WDR48, WDR20, USP46, HIST2H2AC, WDR26, WDR77, HIST2H2BE, ITCH, APP, AR, UBC, NOTCH1, VSX2, CBLB, ZAP70, LAT, GRB2, TRAT1, TSPYL6, GORASP1, RNF19B, GPR161, VSX1, HSPB9 |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for CAB39L_USP12 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for CAB39L_USP12 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|